Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-02-15 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 8.05 -752
2025-02-15 QTRX / Quanterix Corporation 4 Sriram Vandana F - Taxes D 8.05 -92
2025-02-15 ILMN / Illumina, Inc. 4 Barnard Steven F - Taxes D 101.09 -529
2025-02-15 ILMN / Illumina, Inc. 4 Leckman Patricia F - Taxes D 101.09 -644
2025-02-15 ILMN / Illumina, Inc. 4 Pegels Kevin Carl F - Taxes D 101.09 -565
2025-02-15 ILMN / Illumina, Inc. 4 Thaysen Jacob F - Taxes D 101.09 -2,064
2025-02-15 BNGO / Bionano Genomics, Inc. 4 Dixon Jonathan V. F - Taxes D 5.73 -6
2025-02-15 BNGO / Bionano Genomics, Inc. 4 Borodkin Mark F - Taxes D 5.73 -20
2025-02-15 BRKR / Bruker Corporation 4 Bures Thomas A - Award D 2,972
2025-02-15 BRKR / Bruker Corporation 4 ROSENTHAL BOB A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 PACKER RICHARD A A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 Perkins Adelene Q A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 ORNELL JOHN A A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 Anderson Bonnie H A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 Friend Cynthia M A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 Requardt Hermann Fritz A - Award D 3,298
2025-02-15 BRKR / Bruker Corporation 4 LINTON WILLIAM A A - Award D 3,298
2025-02-11 MTD / Mettler-Toledo International Inc. 4 de la Guerroniere Marc S - Sale D 1333.52 -199
2025-02-11 MTD / Mettler-Toledo International Inc. 4 de la Guerroniere Marc S - Sale D 1331.42 -689
2025-02-11 RPID / Rapid Micro Biosystems, Inc. 4 WIRTJES SEAN M F - Taxes D 2.68 -4,621
2025-02-11 RPID / Rapid Micro Biosystems, Inc. 4 Wilson John J. Addington F - Taxes D 2.68 -7,075
2025-02-11 RPID / Rapid Micro Biosystems, Inc. 4 Spignesi Robert G. Jr. F - Taxes D 2.68 -10,755
2025-02-10 MTD / Mettler-Toledo International Inc. 4 Keller Gerry S - Sale D 1350.29 -36
2025-02-10 MTD / Mettler-Toledo International Inc. 4 Keller Gerry S - Sale D 1351.41 -564
2025-02-10 MTD / Mettler-Toledo International Inc. 4 Keller Gerry M - Exercise D 720.81 600
2025-02-09 EYPT / EyePoint Pharmaceuticals, Inc. 4 Lurker Nancy M - Exercise D 20,000
2025-02-09 EYPT / EyePoint Pharmaceuticals, Inc. 4 Elston George M - Exercise D 5,834
2025-02-09 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. M - Exercise D 7,000
2025-02-09 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. F - Taxes D 6.495 -2,055
2025-02-06 RVTY / Revvity, Inc. 4 McMurry-Heath Michelle S - Sale D 119.49 -1,970
2025-02-06 RPID / Rapid Micro Biosystems, Inc. 4 WIRTJES SEAN M F - Taxes D 3.10 -5,891
2025-02-06 RPID / Rapid Micro Biosystems, Inc. 4 Spignesi Robert G. Jr. F - Taxes D 3.10 -13,052
2025-02-06 RPID / Rapid Micro Biosystems, Inc. 4 Wilson John J. Addington F - Taxes D 3.10 -4,505
2025-02-05 WAT / Waters Corporation 4 Chaubal Amol A - Award D 833
2025-02-05 WAT / Waters Corporation 4 Chaubal Amol A - Award D 3,317
2025-02-05 WAT / Waters Corporation 4 Carpio Robert L III A - Award D 543
2025-02-05 WAT / Waters Corporation 4 Bennett Jianqing A - Award D 2,618
2025-02-05 WAT / Waters Corporation 4 Batra Udit A - Award D 3,622
2025-02-05 WAT / Waters Corporation 4 Batra Udit A - Award D 11,349
2025-02-05 WAT / Waters Corporation 4 Bennett Jianqing A - Award D 615
2025-02-04 SEER / Seer, Inc. 4 Horn David R. S - Sale D 2.2365 -3,550
2025-02-04 SEER / Seer, Inc. 4 Farokhzad Omid S - Sale D 2.2365 -8,068
2025-02-04 RVTY / Revvity, Inc. 4 Goldberg Joel S F - Taxes D 123.69 -650
2025-02-04 RVTY / Revvity, Inc. 4 Singh Prahlad R. F - Taxes D 123.69 -4,857
2025-02-04 RVTY / Revvity, Inc. 4 Vohra Tajinder F - Taxes D 123.69 -307
2025-02-04 RVTY / Revvity, Inc. 4 Victor Miriame F - Taxes D 123.69 -342
2025-02-04 RVTY / Revvity, Inc. 4 Victor Miriame A - Award D 4,160
2025-02-04 RVTY / Revvity, Inc. 4 Krakowiak Maxwell A - Award D 5,709
2025-02-04 QTRX / Quanterix Corporation 4 Sriram Vandana A - Award D 50,712
2025-02-04 RVTY / Revvity, Inc. 4 Goldberg Joel S A - Award D 4,939
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)